UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | P | R | S | T | U | V | W
Number of items: 131.

A

Ah-See, MLW and Makris, A and Burcombe, RJ and Davies, C and Cladd, HJ and Padhani, AR and Harris, AL (2003) Evaluation of plasma & serum vascular endothelial growth factor (VEGF) during neoadjuvant chemotherapy for primary breast cancer. British Journal of Cancer , 88 S44 - S44.

Ah-See, MLW and Taylor, NJ and Makris, A and Burcombe, RJ and Stirling, JJ and Cladd, HJ and Leach, MO and Padhani, AR (2003) Valuation of multi-functional dynamic contrast-enhanced MRI to predict response to neoadjuvant chemotherapy in primary breast cancer. British Journal of Cancer , 88 S41 - S41.

Ahmedzai, S and Hoskin, PJ (2003) Assessment and management of malignant disease. In: Muers, MF, (ed.) Oxford Textbook: Supportive Care in Respiratory Disease. Oxford University Press: Oxford.

Ann, F (2003) Thalidomide: horror and redemption. Cancer Nursing Practice , 2 (25) 10 - 12.

Ardeshna, KM and Smith, P and Norton, A and Hancock, BW and Hoskin, PJ and MacLennan, KA and Marcus, RE and Jelliffe, A and Hudson, GV and Linch, DC and Brit Natl Lymphoma Invest, (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. LANCET , 362 (9383) 516 - 522.

Arkenau, H-T and Kruse, F and Jend, HH and Porschen, R (2003) Differential diagnosis of Morbus Crohns disease: Intussusception of the colon | Zur differenzialdiagnose des Morbus Crohn: Invagination des kolons. Zeitschrift fur Gastroenterologie , 41 (7) 663 - 666.

Arkenau, HT and Bermann, A and Rettig, K and Strohmeyer, G and Porschen, R and Arbeitsgemeinschaft Gastrointestinale Onkologie, (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol , 14 (3) 395 - 399.

Arkenau, HT and Kruse, F and Jend, HH and Porschen, R (2003) [Differential diagnosis of morbus Crohn disease: intussusception of the colon]. Z Gastroenterol , 41 (7) 663 - 666. 10.1055/s-2003-40549.

Assersohn, L and Salter, J and Powles, TJ and A'Hern, R and Makris, A and Gregory, RK and Chang, J and Dowsett, M (2003) Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer. Breast Cancer Research and Treatment , 82 (2) 113 - 123.

Atalay, G and Biganzoli, L and Renard, F and Paridaens, R and Cufer, T and Coleman, R and Calvert, AH and Gamucci, T and Minisini, A and Therasse, P and Piccart, MJ and EORTC Breast Canc Early Clin, (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. EUR J CANCER , 39 (17) 2439 - 2449. 10.1016/S0959-8049(03)00601-4.

B

Balk, J and Chew, SK and Leaver, CJ and McCabe, PF (2003) The intermembrane space of plant mitochondria contains a DNase activity that may be involved in programmed cell death. Plant J , 34 (5) 573 - 583.

BBC, NO (2003) Blood test spots 'asbestos cancer'. UNSPECIFIED

BBC, NO (2003) Scans help spot lung cancer early. UNSPECIFIED

BBC, NO (2003) Thalidomide trials to fight cancer. UNSPECIFIED

BBC, NO (2003) Warning to heed lung cancer signs. UNSPECIFIED

BBC, R4 (2003) Thalidomide Trial. UNSPECIFIED

Beresford, M and Glynne-Jones, R and Makris, A and Harrison, M (2003) Lymph node staging following preoperative chemoradiation in rectal cancer. British Journal of Cancer , 88 S21 - S21.

Birtle, AJ and Freeman, A and Masters, JRW and Payne, HA and Harland, SJ (2003) Clinical Features of Patients Who Present with Metastatic Prostate Carcinoma and Serum Prostate-Specific Antigen (PSA) Levels < 10 ng/mL: The "PSA Negative" Patients. Cancer , 98 (11) 2362 - 2367.

Brada, M and Viviers, L and Abson, C and Hines, F and Britton, J and Ashley, S and Sardell, S and Traish, D and Gonsalves, A and Wilkins, P and Westbury, C (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol , 14 (12) 1715 - 1721.

Burcombe, RJ and Makris, A and Pittam, M and Finer, N (2003) Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast , 12 (4) 290 - 293.

C

Calabrese, CR and Batey, MA and Thomas, HD and Durkacz, BW and Wang, LZ and Kyle, S and Skalitzky, D and Li, JK and Zhang, C and Boritzki, T and Maegley, K and Calvert, AH and Hostomsky, Z and Newell, DR and Curtin, NJ (2003) Identification of potent nontoxic poly(ADP-ribose) polymerase-1 inhibitors: Chemopotentiation and pharmacological studies. CLIN CANCER RES , 9 (7) 2711 - 2718.

Calvert, H (2003) Developing drugs for cancer: Striking balance between clinical pragmatism and scientific allure. In: BRITISH JOURNAL OF CANCER. (pp. S7 - S7). NATURE PUBLISHING GROUP

Calvert, H (2003) Pemetrexed (Alimta): A promising new agent for the treatment of breast cancer. SEMINARS IN ONCOLOGY , 30 (2) 2 - 5. 10.1053/sonc.2003.37267.

Carnell, D and Smith, R and Taylor, J and Stirling, J and Hoskin, P and Padhani, A (2003) Evaluation of hypoxia within human prostate carcinoma using quantified bold MRI and pimonidazole immunohistochemical mapping. British Journal of Cancer , 88 S12 - S12.

Carnell, DM and Daley, FM and Smith, RE and Hoskin, P and Murray, GI and Everett, SA (2003) CYP1B1 protein expression in prostate carcinoma. British Journal of Cancer , 88 S34 - S34.

Catherine, E (2003) Thalidomide used in trials to cure cancer. Camden New Journal 25 - ?.

Clingen, PH and DeSilva, IU and Ghadessy, FJ and Thurston, DE and Hartley, JA (2003) The role of nucleotide excision repair and homologous recombination in the sensitivity of mammalian cells to the minor groove crosslinking pyrrolo[2,1-c][1,4]benzodiazepine dimmer SJG-136(NSC694501). In: Proceeding of the American Association for Cancer Research. (pp. 2672 - ?).

Corrie, P and Spanswick, VJ and Sehmbi, R and Jonson, A and Shaw, J and Dowen, S and Biswas, S and Blagden, S and Hartley, JA (2003) Increased persistence of treosulfan-induced DNA interstrand crosslinks when combined with gemcitabine: Proof of principle within a phase I trial. In: Proceeding of the American Society of Clinical Oncology. (pp. 128 - ?).

D

Daly, ME and Makris, A and Reed, M and Lewis, CE (2003) Hemostatic regulators of tumor angiogenesis: A source of antiangiogenic agents for cancer treatment? Journal of the National Cancer Institute , 95 (22) 1660 - 1673.

Dangoor, A and Ranson, M and Lee, SM and Beech, J and Sherlock, DJ and Wilkinson, PM and Valle, JW (2003) Treatment of inoperable hepatocellular carcinoma (HCC) with pegylated liposomal doxorubicin (Caelyx). In: (Proceedings) 2003 ASCO Annual Meeting/39th Annual Meeting, Chicago, Illinois.. (pp. 361 - ?). Proceedings of the American Society of Clinical Oncology

David, F (2003) Birth defects drug is poised for comeback. Financial Times

Davis, AM and Dische, S and Gerber, L and Saunders, M and Leung, SF and O'Sullivan, B (2003) Measuring postirradiation subcutaneous soft-tissue fibrosis: State-of-the-art and future directions. Seminars in Radiation Oncology , 13 (3) 203 - 213.

Dearling, JL and Flynn, AA and Sutcliffe-Goulden, J and Boden, R and Boxer, GM and Begent, RHJ and Pedley, RB (2003) Deoxyglucose microdistribution in major pathophysiological tumour compartments. In: Nuclear Medicine Communication. (pp. 24 - ?).

DeCanha, S and Hoskin, PJ (2003) Current thinking of the role of radiotherapy in metastatic disease. In: Miles, A, (ed.) Key Advances in the effective Management of Breast Cancer. Royal College of Physicians: London.

Dische, S and Saunders, MI (2003) Complexity and simplicity in the measurement and recording of the adverse effects of cancer treatment. Radiotherapy And Oncology , 66 (3) 249 - 251.

Dittrich, C and Dumez, H and Calvert, H and Hanauske, A and Faber, M and Wanders, J and Yule, M and Ravic, M and Fumoleau, P (2003) Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumors. CLIN CANCER RES , 9 (14) 5195 - 5204.

E

Eccersley, AJ and Wilson, EM and Makris, A and Novell, JR (2003) Referral guidelines for colorectal cancer - do they work? Annals of the Royal College of Surgeons of England , 85 (2) 107 - 110.

F

Flynn, AA and Pedley, RB and Green, AJ and Boxer, GM and Dearling, J and Boden, RABRHJ (2003) The heterogeneity of antibody distribution in kidney and its influence on dosimetry. Radiation Research , 159 182 - 189.

Flynn, AA and Pedley, RB and Green, AJ and Dearling, JL and El-Emir, E and Boxer, GM and Boden, R and Begent, RH (2003) The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. Radiat Res , 159 (2) 182 - 189.

Flynn, AA and Pedley, RB and Green, AJ and Dearling, JL and El-Emir, E and Boxer, GM and Boden, R and Begent, RHJ (2003) The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. RADIAT RES , 159 (2) 182 - 189.

Friedmann, BJ and Caplin, M and Hartley, JA and Hochhauser, D (2003) UNSPECIFIED In: Proc. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Clinical Cancer Research

Friedmann, BJ and Caplin, M and Hartley, JA and Hochhauser, D (2003) Modulation of the activity of chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib ('Iressa', ZD1839) in human cancer cell lines. In: CLINICAL CANCER RESEARCH. (pp. 6094S - 6094S). AMER ASSOC CANCER RESEARCH

G

Gaffan, J and Holden, L and Newlands, ES and Short, D and Fuller, S and Begent, RHJ and Rustin, GJS and Seckl, MJ (2003) Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study. BRIT J CANCER , 89 (10) 1849 - 1854. 10.1038/sj.bjc.6601383.

Grigg, A and Solal-Celigny, P and Hoskin, P and Taylor, K and McMillan, A and Forstpointner, R and Bacon, P and Renwick, J and Hiddemann, W (2003) Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma. Leukemia and Lymphoma , 44 (9) 1503 - 1508.

H

Hammond, KL and Loynes, HE and Folarin, AA and Smith, J and Whitfield, TT (2003) Hedgehog signalling is required for correct anteroposterior patterning of the zebrafish otic vesicle. DEVELOPMENT , 130 (7) 1403 - 1417. 10.1242/dev.00360.

Harney, J and Goodchild, K and Phillips, H and Glynne-Jones, R and Hoskin, PJ and Saunders, MI (2003) A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus. Clinical Oncology , 15 (3) 109 - 114.

Harney, J and Shah, N and Short, S and Saunders, M and Joiner, M (2003) Low dose hyper-radiosensitivity-a clinical assessment. In: International journal of radiation oncology biology physics. (pp. Abs 173 - ?).

Hoskin, PJ (2003) Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treatment Reviews , 29 (4) 321 - 327.

Hoskin, PJ (2003) Case selection in the management of cerebral metastases. Clinical Oncology , 15 (7) 420 - 421.

Hoskin, PJ (2003) What are the oncologist's need. European Journal of Nuclear Medicine and Molecular Imaging , 30 (S1) S37 - S41. 10.1007/s00259-003-1158-5.

Hoskin, PJ (2003) Radiotherapy in symptom management. In: Doyle, D and Hanks, GW and Cherny, N and Calman, K, (eds.) Oxford Textbook of Palliative Care. Oxford University Press.: Oxford.

Hoskin, PJ (2003) Evaluation and management of the patient with bone metastases at presentation. In: Jasmin, C and Caanna, R and Coia, L and Coleman, R and Diel, I, (eds.) Textbook of Bone Metastases. Wiley: Chichester.

Hoskin, PJ and Bownes, PJ and Ostler, P and Walker, K and Bryant, L (2003) High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiotherapy And Oncology , 68 (3) 285 - 288.

Hoskin, PJ and Grover, A and Bhana, R (2003) Metastatic spinal cord compression: radiotherapy outcome and dose fractionation. Radiotherapy And Oncology , 68 (2) 175 - 180.

Hoskin, PJ and O'Doherty, MJ (2003) Lymphoma: Diagnosis and Management. European Journal Of Nuclear Medicine and Molecular Imaging , 30 (S1) BP87 - BP98. 10.1007/s00259-003-1342-7.

Hoskin, PJ and Sibtain, A and Daley, FM and Wilson, GD (2003) GLUTI and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. British Journal of Cancer , 89 (7) 1290 - 1297. 10.1038/sj.bjc.6601260.

Howie, AJ and Turhan, N and Adu, D (2003) Powerful morphometric indicator of prognosis in lupus nephritis. QJM , 96 (6) 411 - 420. 10.1097/01.TP.0000120177.44144.FF.

Huhalov, A and Spencer, DI and Chester, KA (2003) Mapping Antibody:Antigen Interactions by Mass Spectrometry and Bioinformatics. In: Lo, BKC, (ed.) Antibody Engineering Methods and Protocols. (465 - 480). Humana Press

I

Irwin, HL and Corcoran, F and Boxer, GM and Pedley, RB and Dearling, J and Hartley, JM and Begent, RHJ and Sharma, SK (2003) Isolation of tumour cells from peripheral blood for potential assessment of response to antibody directed enzyme prodrug therapy (ADEPT). British Journal of Cancer , 88 S37 - S37.

Irwin, HL and Corcoran, F and Boxer, GM and Pedley, RB and Dearling, J and Hartley, JM and Begent, RHJ and Sharma, SK (2003) Isolation of tumour cells from peripheral blood for potential assessment of response to antibody directed enzyme prodrug therapy (ADEPT). In: BRITISH JOURNAL OF CANCER. (pp. S37 - S37). NATURE PUBLISHING GROUP

J

Jacqui, T (2003) Thalidomide used to fight lung cancer. ‘Deformity’ drug in new trial. The Sun 16 - ?.

James, L and Lee, SM (2003) A phase II study of carboplatin/etoposide with thalidomide in small cell lung cancer (SCLC). In: (Proceedings) 10th World Conference on Lung Cancer, Vancouver.. (pp. S183 - ?). Lung Cancer

James, M (2003) Lung cancer curbed in thalidomide trial. The Guardian

Janinis, J and Patriki, M and Vini, L and Aravantinos, G and Whelan, JS (2003) The pharmacological treatment of aggressive fibromatosis: a systematic review. Annals of Oncology , 14 181 - 190.

John, G (2003) Thalidomide. An unlikely cure? Guardian 60 - ?.

John, T and Ottley, C and Pearson, G and Nowell, G and Calvert, H and Tilby, M (2003) Sensitive determination of BBR 3464 and cisplatin DNA adduct levels in clinical samples using ICP-MS and PIMMS. In: BRITISH JOURNAL OF CANCER. (pp. S42 - S42). NATURE PUBLISHING GROUP

John, T and Ottley, CJ and Pearson, DG and Nowell, GM and Calvert, H and Tilby, MJ (2003) Determination, by ICP-MS, of background and BBR 3464 induced levels of platinum bound to DNA isolated from blood cells: A comparison of the sensitivity of the Perkin Elmer Sciex Elan 6000 and the thermofinnigan Neptune instruments. In: Holland, JG and Tanner, SD, (eds.) PLASMA SOURCE MASS SPECTROMETRY: APPLICATIONS AND EMERGING TECHNOLOGIES. (pp. 82 - 90). ROYAL SOC CHEMISTRY

K

Kate, N (2003) Bag Drug Makes Good. TIME Magazine 59 - ?.

Kauppila, S and Maaty, WS and Chen, P and Tomar, RS and Eby, MT and Chapo, J and Chew, S and Rathore, N and Zachariah, S and Sinha, SK and Abrams, JM and Chaudhary, PM (2003) Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene , 22 (31) 4860 - 4867. 10.1038/sj.onc.1206715.

Khalil, AA and Bentzen, SM and Bernier, J and Saunders, MI and Horiot, JC and Van Den Bogaert, W and Cummings, BJ and Dische, S (2003) Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. International Journal of Radiation Oncology Biology Physics , 55 (3) 568 - 575.

Kostoula, V and Khan, K and Savage, K and Hochhauser, D and Stubbs, M and McStay, M and Dhillon, AP and Caplin, ME (2003) Expression of c-kit (cd117) in neuroendocrine tumours - a target for therapy? ENDOCR-RELAT CANCER , 10 (4) 508 - 508.

Kotecha, MT and Hercus, L and Lees, SM and Hartley, JA and Hochhauser, D (2003) Modulation of topoisomerase Iia expression by sequence specific polyamides. In: Proceeding of the American Association for Cancer Research. (pp. 6539 - ?).

Krause, M and Hessel, F and Wohlfarth, J and Zips, D and Hoinkis, C and Foest, H and Short, S and C, J and M, C and Baumann, M (2003) Ultrafractionation in A7 malignant glioma in nude mice. 377 - 383.

Kristeleit, RS and Stimson, L and Workman, P and Aherne, GW (2003) Effects of the hydroxamic acid histone deacetylase inhibitors trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA) and LAQ824 on histone and protein acetylation. In: CLINICAL CANCER RESEARCH. (pp. 6107S - 6107S). AMER ASSOC CANCER RESEARCH

L

Lacombe, D and Butler-Smith, A and Therasse, P and Fumoleau, P and Burtles, S and Calvert, H and Marsoni, S and Sessa, C and Verweij, J (2003) Cancer drug development in Europe: A selection of new agents under development at the European Drug Development Network. CANCER INVEST , 21 (1) 137 - 147. 10.1081/CNV-120016408.

Lambert, S and Mason, SJ and Barber, LJ and Hartley, JA and Pearce, JA and Carr, AM and McHugh, PJ (2003) Schizosaccharomyces pombe checkpoint response to DNA interstrand cross-links. MOL CELL BIOL , 23 (13) 4728 - 4737.

Lee, M and Wilson, D and Lacy, E and Grandillo, J and Le, M and Kiakos, K and Hartley, J (2003) Microcalorimetry and DNase I footprinting studies on the molecular recognition of T/G mismatched base pairs by stacked polyamides. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U199 - U200). AMER CHEMICAL SOC

Lee, YC and Flora, R and McCafferty, JA and Gor, J and Tsaneva, IR and Perkins, SJ (2003) A tetramer-octamer equilibrium in Mycobacterium leprae and Escherichia coli RuvA by analytical ultracentrifugation. J MOL BIOL , 333 (4) 677 - 682. 10.1016/j.jmb.2003.08.047.

Leonard, P and Sharp, T and Henderson, S and Hewitt, D and Pringle, J and Sandison, A and Goodship, A and Whelan, J and Boshoff, C (2003) Gene expression array profile of human osteosarcoma. BRIT J CANCER , 89 (12) 2284 - 2288. 10.1038/sj.bjc.6601389.

Lewis, I and Nooij, M and Whelan, J and Casak, S and Memon, M and Taminiau, A and Hogendoorn, P and Grimer, R and Weeden, S and Uscinska, B and Glabbeke, MV and Intergroup, AKOBOTEO (2003) Chemotherapy at standard or increased dose intensity in patients with operable osteosarcoma of the extremity: A randomised controlled trial of the European Osteosarcoma Intergroup (ISRCTN 86294690). In: SIOP, Cairo, Oct 2003.

LoRusso, PM and Herbst, RS and Rischin, D and Ranson, M and Calvert, H and Raymond, E and Kieback, D and Kaye, S and Gianni, L and Harris, A and Bjork, T and Maddox, AM and Rothenberg, ML and Small, EJ and Rubin, EH and Feyereislova, A and Heyes, A and Averbuch, SD and Ochs, J and Baselga, J (2003) Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. CLIN CANCER RES , 9 (6) 2040 - 2048.

Lyn, BE and Wilson, EM and Williams, FJ and Saunders, MI and Phillips, H (2003) Chart to Chartwel to Chemotherapy and Chartwel in Non-Small Cell Lung Cancer. British Journal of Cancer , 88 S23 - S23.

M

Mackay, HJ and O'Brien, M and Hill, S and Lee, SM and Thatcher, N and Smith, IE and Dunlop, DJ (2003) A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancer. Clinical Oncology , 15 (4) 181 - 185.

Makris, A (2003) Critical commentary of: Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin and flourouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer:an EORTC-NCIC-SAKK multicenter study. Women's Oncology Review , 3 237 - 238.

Martin, F and Chowdhury, S and Neil, SJ and Chester, KA and Cosset, FL and Collins, MK (2003) Targeted retroviral infection of tumor cells by receptor cooperation. J VIROL , 77 (4) 2753 - 2756. 10.1128/JVI.77.4.2753-2756.2003.

Martin, M and Spielmann, M and Namer, M and duBois, A and Unger, C and Dodwell, D and Vodvarka, P and Lind, M and Calvert, H and Casado, A and Zelek, L and Lluch, A and Carrasco, E and Kayitalire, L and Zielinski, C (2003) Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines. ANN ONCOL , 14 (8) 1246 - 1252. 10.1093/annonc/mdg339.

Mayer, A and Tsiompanou, E and Flynn, AA and Pedley, RB and Dearling, J and Boden, R and Begent, RHJ (2003) Higher dose and dose-rate in smaller tumors result in improved tumor control. CANCER INVEST , 21 (3) 382 - 388. 10.1081/CNV-120018229.

Meyer, T and McTiernan, A and Whelan, J (2003) A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours. Sarcoma , 7 (1) 13 - 17. 10.1080/1357714031000114192.
An open access publication

Murphy, DM and Dolbear, C and Moller, H and Whelan, JS and Pinkerton, CR (2003) The incidence of cancer in adolescents and young adults in south east England: an analysis of Thames Cancer Registry data 1998-2000. In: British Cancer Research Meeting, Bournemouth June 2003. Br J Cancer 2003; 88 Suppl 1:S17.

N

Nathan, PD and Hochhauser, D (2003) Pathogenesis of Cancer. In: Kirk, RM and Ribbans, WJ, (eds.) Clinical Surgery in General. Charchill Livingstone: London.

Nooij, M and Lewis, I and Whelan, JS and Casak, S and Memon, M and Hogendoorn, P and Weeden, S and Uscinska, B and van, GM and Kirkpatrick, A (2003) Does increasing dose intensity in patients with operable osteosarcoma of the extremity improve outcome? A randomised controlled trial of the European Osteosarcoma Intergroup (EOI). In: ECCO, Copenhagen Oct 2003.

P

Plummer, R and Rees, C and Hughes, A and Beale, P and Highley, M and Trigo, J and Gokul, S and Judson, I and Calvert, H and Jackman, A and Mitchell, F and Smith, R and Douglass, E (2003) A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor. CLIN CANCER RES , 9 (4) 1313 - 1322.

R

Redpath, JL and Short, SC and Woodcock, M and Johnston, P (2003) Low dose reduction in transformation frequency compared to unirradiated controls: the role of hyper-radiosensitivity. Radiation Research , 159 433 - 436.

Reigner, B and Watanabe, T and Schüller, J and Lucraft, H and Sasaki, Y and Bridgewater, J and Saeki, T and McAleer, J and Kuranami, M and Poole, C and Kimura, M and Monkhouse, J and Yorulmaz, C and Weidekamm, E and Grange, S (2003) Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer. Cancer Chemother Pharmacol , 52 (3) 193 - 201. 10.1007/s00280-003-0642-8.

Rob, B (2003) Controversial drug in lung cancer trials. Highbury & Islington Express

Roos, DE and Davis, SR and Turner, SL and O'Brien, PC and Spry, NA and Burmeister, BH and Hoskin, PJ and Ball, DL (2003) Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05). Radiotherapy And Oncology , 67 (2) 207 - 212.

S

Sarker, D and Williams, MT and Buscombe, J and Caplin, M and Hochhauser, D and Begent, R and Meyer, T (2003) Streptozocin, 5-fluorouracil/folinic acid and cisplatin (FCiSt) for advanced neuroendocrine tumours. British Journal of Cancer , 88 S65 - S65.

Saunders, M and Palmer, AM and Millard, RK and Preece, AW (2003) Doses to fetal and maternal organs from intravenous (FeCl3)-Fe- 59 or (CoCl2)-Co-57. Radiation Protection Dosimetry , 106 (1) 63 - 69.

Sayle, KL and Bentley, J and Boyle, FT and Calvert, AH and Cheng, YZ and Curtin, NJ and Endicott, JA and Golding, BT and Hardcastle, IR and Jewsbury, P and Mesguiche, V and Newell, DR and Noble, MEM and Parsons, RJ and Pratt, DJ and Wang, LZ and Griffin, RJ (2003) Structure-based design of 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinases 1 and 2. BIOORG MED CHEM LETT , 13 (18) 3079 - 3082. 10.1016/S0960-894X(03)00651-6.

Sharma, SK and Pedley, RB and Irwin, HL and El Emir, E and Boxer, GM and Boden, RW and Chester, KA and Begent, RHJ (2003) The effect of ADEPT, as a single or combined therapy, in two colorectal xenografts. In: British Journal of Cancer. (pp. S37 - S37).

Sharma, SK and Pedley, RB and Irwin, HL and El-Emir, E and Boxer, GM and Boden, RW and Chester, KA and Begent, RHJ (2003) The effect of adept, as a single or combined therapy, in two colorectal xenografts. In: BRITISH JOURNAL OF CANCER. (pp. S37 - S37). NATURE PUBLISHING GROUP

Short, S (2003) UNSPECIFIED In: (Proceedings) 2nd International Conference on Translational Research in Radiation Oncology.

Short, S (2003) External beam and conformal radiotherapy in the management of gliomas. In: Westphal,, (ed.) Local therapies for glioma. Springer

Short, S and Buffa, F and Bourne, S and Johnston, P and Bentzen, S (2003) Determining dose response relationships of gene expression in human tumour cells after low radiation doses using micro-array analysis. In: Proc EU-US Molecular Signatures of DNA Damage Workshop.

Short, S and C, B and F, B and S, J and P, B and S, M (2003) UNSPECIFIED In: (Proceedings) EU-US Molecular Signatures of DNA Damage Workshop.

Short, S and C, H and J, (2003) Radiobiology and vascular targeting in glioma. Current opinion in neurology , 16 651 - 655.

Sibtain, A and Saunders, MI and Bentzen, SM and Hoskin, PJ (2003) Pre-treatment Haemoglobin Concentration in Accelerated and Conventional Radiotherapy for Non-small Cell Lung Carcinoma. Clinical Oncology , 16 58 - 62.

Skalitzky, DJ and Marakovits, JT and Maegley, KA and Ekker, A and Yu, XH and Hostomsky, Z and Webber, SE and Eastman, BW and Almassy, R and Li, JK and Curtin, NJ and Newell, DR and Calvert, AH and Griffin, RJ and Golding, BT (2003) Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J MED CHEM , 46 (2) 210 - 213. 10.1021/jm0255769.

Smellie, M and Bose, DS and Thompson, AS and Jenkins, TC and Hartley, JA and Thurston, DE (2003) Sequence-selective recognition of duplex DNA through covalent interstrand cross-linking: Kinetic and molecular modeling studies with pyrrolobenzodiazepine dimers. BIOCHEMISTRY-US , 42 (27) 8232 - 8239. 10.1021/bi034313t.

Stein, ME and Lewis, DC and Gershuny, AR and Quigley, MM and Zaidan, J and Siegelmann-Danieli, N and Whelan, JS and Subramanian, R (2003) Trauma as an etiologic factor of primary bone lymphoma: a report of 4 cases. Journal of BUON , 8 163 - 166.

Strauss, SJ and Marples, M and Napier, MP and Meyer, T and Boxall, J and Rustin, GJS (2003) A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma. British Journal of Cancer , 89 (10) 1901 - 1905.

Strauss, SJ and McTiernan, A and Driver, D and Hall-Craggs, M and Sandison, A and Cassoni, AM and Kilby, A and Michelagnoli, M and Pringle, J and Cobb, J and Briggs, T and Cannon, S and Witt, J and Whelan, JS (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. Journal of Clinical Oncology , 21 (15) 2974 - 2981.

Strauss, SJ and McTiernan, A and Driver, D and Hall-Craggs, M and Sandison, A and Cassoni, AM and Kilby, A and Michelagnoli, M and Pringle, J and Cobb, J and Briggs, T and Cannon, S and Witt, J and Whelan, JS (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. J CLIN ONCOL , 21 (15) 2974 - 2981. 10.1200/JCO.2003.04.106.

T

The, T (2003) Conditions: Lung Cancer.

Toth, J and Henry, J and Taherbhai, Z and Staples, T and Summerville, K and Handl, H and Hudson, S and Kiakos, K and Hartley, J and Lee, M (2003) Cytotoxicity and sequence specificity of C- and N-terminus conjugates of N-methylpyrrole polyamides with seco-cyclopropaneindoline. MED CHEM RES , 12 (2) 87 - 93.

Tsotinis, A and Vlachou, M and Kiakos, K and Hartley, JA and Thurston, DE (2003) Design and synthesis of two cytotoxic analogs of the novel pyrrolo[1 ',2 ': 1,2][1,4]diazepin [7,6-b]indol-5(6H)-one nucleus. CHEM LETT , 32 (6) 512 - 513. 10.1246/cl.2003.512.

Turner, NC and Hochhauser, D (2003) New Targets in oesophagogastric cancer. In: Key Advances in Clinical Practice: The Effective Management of Oesophagogastric Cancer. Aesculapius Press

U

UCL, PA (2003) Scans help spot lung cancer early. 29 - ?.

Urbaniak, MD and Frost, LM and Bingham, JP and Kelland, LR and Hartley, JA and Woolfson, DN and Caddick, S (2003) Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophore. BIOORG MED CHEM LETT , 13 (12) 2025 - 2027. 10.1016/S0960-894X(03)00328-7.

V

Venables, K and Winfield, EA and Aird, EGA and Hoskin, PJ (2003) Three-dimensional distribution of radiation within the breast: An intercomparison of departments participating in the start trial of breast radiotherapy fractionation. International Journal of Radiation Oncology Biology Physics , 55 (1) 271 - 279.

W

Wells, G and Gale, T and Hardy, A and Hamaguchi, A and Hartley, JA and Wilkinson, GP and Loadman, P and Jenkins, TC and Howard, PH and Thurston, DE (2003) Pyrrolobenzodiazepine-polyamide libraries:synthesis and DNA binding selectivity. Proceeding of the American Association for Cancer Research. In: Proceeding of the American Association for Cancer Research. (pp. 452 - ?).

Wells, P and Aboagye, E and Gunn, RN and Osman, S and Boddy, AV and Taylor, GA and Rafi, I and Hughes, AN and Calvert, AH and Price, PM and Newell, DR (2003) 2-[C-11]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337. J NATL CANCER I , 95 (9) 675 - 682.

Westbury, CB and Harrington, KJ and Rhys-Evans, P and Archer, DJ and Searle, AE and Henk, JM and Black, CM and Nutting, CM (2003) Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck. POSTGRAD MED J , 79 (929) 176 - 177.

Whelan, J (2003) Studies on cellular sensitivity and resistance to cytosine arabinoside. UNSPECIFIED thesis, UNSPECIFIED.

Whelan, J (2003) Where should teenagers with cancer be treated? European Journal of Cancer , 39 (18) 2573 - 2578.

Whelan, JS (2003) Working with Adolescents. ESMO Summer Educational Conference, Edinburgh June 2003. In: Annals Oncol. (pp. 42 - ?).

Whelan, JS and McTiernan, A (2003) Survival after recurrence of Ewing’s tumour is improved by high dose chemotherapy and surgery. Results of a retrospective analysis of 116 patients. In: Connective Tissue Oncology Society, Barcelona Nov 2003.

Whelan, JS and O, SC and Stanway, S and Ng, S (2003) How should glomerular filtration rates be measured in teenagers having chemotherapy? In: British Cancer Research Meeting, Bournemouth June 2003. Br J Cancer 2003; 88 Suppl 1:S53.

Wilkinson, GP and Loadman, P and Taylor, J and Jenkins, TC and Swaine, D and Double, JA and Spanswick, VJ and Hartley, JA and Gregson, SJ and Howard, PH and Thurston, DE (2003) Pharmacokinetic and intracellular pharmacological characteristics of the novel pyrrolobenzodiazepine (PBD) dimmer SJG-136. In: Proceeding of the American Association for Cancer Research. (pp. 1634 - ?).

Winfield, EA and Deighton, A and Venables, K and Hoskin, PJ and Aird, EGA (2003) Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer. British Journal of Radiology , 76 (904) 254 - 259.

Wong, WL and Saunders, M (2003) The impact of FDG PET on the management of occult primary head and neck tumours. Clinical Oncology , 15 (8) 461 - 466.

This list was generated on Tue May 21 07:55:43 2013 BST.